hydrALAZINE Hydrochloride 20 mg / mL Injection 1 mL
Comprehensive product details for sourcing and verification.
| NDC 11 | 63323-0614-55 |
|---|---|
| Product NDC | 63323-0614 |
| Generic Drug Name | hydrALAZINE Hydrochloride |
| Brand Name | hydrALAZINE Hydrochloride |
| Manufacturer | Fresenius Kabi USA, LLC |
| Strength | 20 mg / mL |
| Dosage Form | Injection |
| Drug Type | Intramuscular; Intravenous |
| Package Quantity | 25 Vial, Single-Dose |
| Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-614-55) / 1 mL in 1 VIAL, SINGLE-DOSE (63323-614-21) |
| Active Ingredients | Hydralazine Hydrochloride |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
hydrALAZINE Hydrochloride 20 mg / mL Injection is tracked under NDC 63323-0614-55 and rolls up into product family 63323-0614. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 25 Vial, Single-Dose.
- Manufacturer: Fresenius Kabi USA, LLC.
- Dosage form: Injection.
- Family size: 4 active presentations.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Alternate presentations in this family
These nearby exact-item pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.
Drug Shortage Information
Hydralazine hydrochloride appeared in two separate documented shortage listings between 2015 and 2018, which suggests elevated future supply risk.
Drug Shortage Index family
View HydrALAZINE Hydrochloride in the Drug Shortage IndexCompare related exact NDC products and family-level shortage context for HydrALAZINE Hydrochloride.Source: Public FDA drug shortage records accessed through FDA-owned openFDA drug shortages queries.
This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
hydrALAZINE Hydrochloride 20 mg / mL Injection 1 mL, NDC 63323-0614-55, is a Fresenius Kabi USA, LLC 20 mg / mL injection presentation packaged as 25 Vial, Single-Dose. Historical public shortage information is available for this exact presentation.
NDC search formats
- Canonical NDC 11: 63323-0614-55.
- Digits-only NDC 11: 63323061455.
- Possible 10-digit display format: 63323-614-55 (6332361455).
Helpful product links
- Search by brand name: hydrALAZINE Hydrochloride.
- Exact NDC 11: 63323-0614-55.
- Product family NDC: 63323-0614.
- Other package sizes in this family: 25 Vial, Single-Use.
- Compare related presentations: Hydralazine Hydrochloride 20 mg / mL Injection 1 mL, Hydralazine Hydrochloride 20 mg / mL Injection 1 mL, Hydralazine Hydrochloride 20 mg / mL Injection 1 mL.
Related shortage research
If your team is researching the broader shortage picture, the family page groups related exact NDC items, brand variations, and family-level shortage context in one place.